2016
DOI: 10.3899/jrheum.160425
|View full text |Cite|
|
Sign up to set email alerts
|

Gamma Delta T Cell Subset V Gamma 2+ Expansion Associated with Longterm Infliximab Treatment in a Patient with Ankylosing Spondylitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Interestingly, in contrast to IL23R + IL-17 + Vδ1 + T cells that are expanded in AS, Vδ2 + γδ T cells were found to be increased in patients with AS who were receiving infliximab (anti TNFα) therapy, relative to those not receiving this drug and HC. Most of these Vδ2 + T cells secreted IFNγ and not IL-17 [84].…”
Section: Ankylosing Spondylitis (As)mentioning
confidence: 94%
“…Interestingly, in contrast to IL23R + IL-17 + Vδ1 + T cells that are expanded in AS, Vδ2 + γδ T cells were found to be increased in patients with AS who were receiving infliximab (anti TNFα) therapy, relative to those not receiving this drug and HC. Most of these Vδ2 + T cells secreted IFNγ and not IL-17 [84].…”
Section: Ankylosing Spondylitis (As)mentioning
confidence: 94%